An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy
This study is currently recruiting participants.
Verified May 2017 by Genentech, Inc.
Information provided by (Responsible Party):
First received: May 16, 2012
Last updated: May 10, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||June 30, 2019|
|Estimated Primary Completion Date:||June 30, 2019 (Final data collection date for primary outcome measure)|